Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
Sales | 585,301 | 493,970 | 478,477 | 464,232 | 469,129 |
Cost of Goods | 369,320 | 312,501 | 311,083 | 287,385 | 283,804 |
Gross Profit | 215,981 | 181,469 | 167,394 | 176,847 | 185,325 |
Operating Expenses | 139,591 | 114,141 | 104,649 | 103,170 | 104,443 |
Operating Income | 76,710 | 67,829 | 62,828 | 74,062 | 81,686 |
Interest Expense | 18,643 | 11,191 | 7,724 | 7,667 | 7,403 |
Other Income | 12,221 | 6,402 | 13,949 | 6,544 | 2,633 |
Pre-tax Income | 70,288 | 63,040 | 69,053 | 72,939 | 76,916 |
Income Tax | 17,438 | 9,772 | 98,097 | 19,945 | 22,243 |
Net Income Continuous | 52,850 | 53,268 | -29,044 | 52,994 | 54,673 |
Net Income Discontinuous | 1,529 | -23 | -23 | -39 | -71 |
Minority Interests | 670 | 614 | 782 | 481 | 650 |
Net Income | $53,709 | $52,631 | $-29,849 | $52,474 | $53,952 |
EPS Basic Total Ops | 1.11 | 1.10 | -0.62 | 1.11 | 1.13 |
EPS Basic Continuous Ops | 1.08 | 1.10 | -0.63 | 1.11 | 1.14 |
EPS Basic Discontinuous Ops | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted Total Ops | 1.10 | 1.08 | -0.63 | 1.08 | 1.12 |
EPS Diluted Continuous Ops | 1.06 | 1.08 | -0.64 | 1.09 | 1.12 |
EPS Diluted Discontinuous Ops | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA(a) | $120,106 | $101,039 | $96,312 | $107,527 | $113,485 |